| Size and shape effects in the biodistribution of intravascularly injected particles P Decuzzi, B Godin, T Tanaka, SY Lee, C Chiappini, X Liu, M Ferrari Journal of Controlled Release 141 (3), 320-327, 2010 | 1099 | 2010 |
| Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications E Tasciotti, X Liu, R Bhavane, K Plant, AD Leonard, BK Price, ... Nature nanotechnology 3 (3), 151-157, 2008 | 824 | 2008 |
| Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast JS Ananta, B Godin, R Sethi, L Moriggi, X Liu, RE Serda, R Krishnamurthy, ... Nature nanotechnology 5 (11), 815-821, 2010 | 496 | 2010 |
| Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localized in vivo neovascularization C Chiappini, E De Rosa, JO Martinez, X Liu, J Steele, MM Stevens, ... Nature materials 14 (5), 532-539, 2015 | 447 | 2015 |
| Biodegradable porous silicon barcode nanowires with defined geometry C Chiappini, X Liu, JR Fakhoury, M Ferrari Advanced functional materials 20 (14), 2231-2239, 2010 | 438* | 2010 |
| Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles Z Wang, H Wu, D Fine, J Schmulen, Y Hu, B Godin, JXJ Zhang, X Liu Lab on a Chip 13 (15), 2879-2882, 2013 | 389 | 2013 |
| Sustained small interfering RNA delivery by mesoporous silicon particles T Tanaka, LS Mangala, PE Vivas-Mejia, R Nieves-Alicea, AP Mann, ... Cancer research 70 (9), 3687-3696, 2010 | 371 | 2010 |
| The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows F Gentile, C Chiappini, D Fine, RC Bhavane, MS Peluccio, MMC Cheng, ... Journal of biomechanics 41 (10), 2312-2318, 2008 | 364 | 2008 |
| Enabling individualized therapy through nanotechnology JH Sakamoto, AL van de Ven, B Godin, E Blanco, RE Serda, A Grattoni, ... Pharmacological research 62 (2), 57-89, 2010 | 285 | 2010 |
| An injectable nanoparticle generator enhances delivery of cancer therapeutics R Xu, G Zhang, J Mai, X Deng, V Segura-Ibarra, S Wu, J Shen, H Liu, ... Nature biotechnology 34 (4), 414-418, 2016 | 282 | 2016 |
| Point-of-care technologies for molecular diagnostics using a drop of blood Y Song, YY Huang, X Liu, X Zhang, M Ferrari, L Qin Trends in biotechnology 32 (3), 132-139, 2014 | 244 | 2014 |
| Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics B Godin, E Tasciotti, X Liu, RE Serda, M Ferrari Accounts of chemical research 44 (10), 979-989, 2011 | 227 | 2011 |
| Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution AL Van De Ven, P Kim, JR Fakhoury, G Adriani, J Schmulen, P Moloney, ... Journal of Controlled Release 158 (1), 148-155, 2012 | 212 | 2012 |
| Discoidal porous silicon particles: fabrication and biodistribution in breast cancer bearing mice B Godin, C Chiappini, S Srinivasan, JF Alexander, K Yokoi, M Ferrari, ... Advanced functional materials 22 (20), 4225-4235, 2012 | 206 | 2012 |
| The association of silicon microparticles with endothelial cells in drug delivery to the vasculature RE Serda, J Gu, RC Bhavane, XW Liu, C Chiappini, P Decuzzi, M Ferrari Biomaterials 30 (13), 2440-2448, 2009 | 203 | 2009 |
| Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations V Subbiah, T Shen, SS Terzyan, X Liu, X Hu, KP Patel, M Hu, ... Annals of Oncology 32 (2), 261-268, 2021 | 198 | 2021 |
| The preferential targeting of the diseased microvasculature by disk-like particles G Adriani, MD de Tullio, M Ferrari, F Hussain, G Pascazio, X Liu, ... Biomaterials 33 (22), 5504-5513, 2012 | 182 | 2012 |
| Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation B Godin, J Gu, RE Serda, R Bhavane, E Tasciotti, C Chiappini, X Liu, ... Journal of biomedical materials research Part A 94 (4), 1236-1243, 2010 | 171 | 2010 |
| E‐Selectin‐targeted porous silicon particle for nanoparticle delivery to the bone marrow AP Mann, T Tanaka, A Somasunderam, X Liu, DG Gorenstein, M Ferrari Advanced materials 23 (36), H278-H282, 2011 | 149 | 2011 |
| Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling B Dave, S Granados-Principal, R Zhu, S Benz, S Rabizadeh, ... Proceedings of the National Academy of Sciences 111 (24), 8838-8843, 2014 | 129 | 2014 |
